Spinal Fusion Device Market Size, Share & Trends Analysis Report By Product, By Surgery (Complex Deformity, Degenerative Disc), By Disease Type, By End User (Hospitals, Specialty Clinics), By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The global spinal fusion device size was exhibited at USD 6.50 billion in 2023 and is projected to hit around USD 10.19 billion by 2033, growing at a CAGR of 4.6% during the forecast period 2024 to 2033.

Spinal Fusion Device Market Size 2024 To 2033

Key Takeaways:

  • The thoracolumbar devices segment dominated the market for spinal fusion devices and accounted for the largest revenue share of more than 55.0% in 2023. 
  • The degenerative disc segment dominated the market for spinal fusion devices and accounted for the largest revenue share of over 42.0% in 2023.
  • The minimally invasive surgery segment dominated the market for spinal fusion devices and accounted for the largest revenue share of 64.0% in 2023 as it’s the first preference for spinal fusion surgeries.
  • The hospitals dominated the market for spinal fusion devices and accounted for the largest revenue share of over 60.0% in 2023. 
  • North America dominated the spinal fusion devices market and accounted for the largest revenue share of over 43.0% in 2023.

Spinal Fusion Device Market Report Scope

 Report Coverage  Details
Market Size in 2024 USD 6.50 Billion
Market Size by 2033 USD 10.19 Billion
Growth Rate From 2024 to 2033 CAGR of 4.6%
Base Year 2023
Forecast Period 2024-2033
Segments Covered Product, Disease Type, Surgery, End-User, Region
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regional Scope North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa
Key Companies Profiled Johnson & Johnson Services, Inc. (DePuy Synthes); Stryker; Zimmer Biomet; Orthofix Medical, Inc.; B. Braun Melsungen AG; Medtronic; NuVasive, Inc.; Globus Medical; ATEC Spine, Inc; Captiva Spine, Inc; SeaSpine; Spinal Elements, Inc.; Spine Wave, Inc.; Spineology, Inc.; Xtant Medical Holdings, Inc.

 

Increasing numbers of spinal disorders and the growing geriatric population are boosting the market growth. According to the CDC report, around 34.0% of the adult population and 62.0% of the elderly population got affected by spinal deformities as of 2022. The common causes of spinal fusion injuries are found to be trauma, falls, collisions, or road traffic accidents.

The impact of the COVID-19 pandemic has been witnessed in nearly every industry. Like other healthcare markets, the market for spinal fusion devices has also been significantly affected. COVID-19 has led to postponed or deferred elective surgeries, a decline in sales, and dampened growth rate, among others. The decrease in surgical procedures drastically reduced the demand for devices and products required for spinal fusion. Although urgent and emergent surgeries were performed, there was a steep decline in the total number of procedures. Shortage of ICU beds and surgical rooms has been reported. Industry players witnessed slow growth and low net sales in the first two quarters of 2023.

After the initial impact of the pandemic, companies and governments started undertaking corrective actions to help the economy and businesses recover. These measures included policy and monetary stimuli, easing of restrictions, conditional exemptions, and other strategic initiatives. By Q3 2023, many companies reported recovery in sales with positive projections for the future. For instance, Stryker's spine segment revenue reported double-digit growth of 11.3% in 2021 Q1 as compared to 2023.

Product Insights

The thoracolumbar devices segment dominated the market for spinal fusion devices and accounted for the largest revenue share of more than 55.0% in 2023. The increasing incidence of spinal disorders such as spinal stenosis, excessive kyphosis, and vertebral fracture is further driving the segment. In most of these cases, surgery is the only treatment option. Moreover, fractures in the thoracolumbar area can be the most important reason for surgical intervention. These fractures are either caused by road accidents or bone insufficiency. Bone insufficiency is caused for the reason of underlying settings such as osteoporosis and tumors that eventually weaken the bone and cause fractures.

The cervical segment is expected to grow fast in the market for spinal fusion devices over the forecast period owing to the rise in prevalence of cervical spondylosis in corporate professionals. Cervical spondylosis is a common disorder that is projected to account for 2% of all hospital admissions in the U.S. It is the most recurrent cause of spinal cord dysfunction in patients elder than 55 years. Based on radiologic findings, 90% of women elder than 60 years and 90% of men elder than 50 years have evidence of degenerative changes in the cervical spine, which is expected to support segment growth in the coming years.

Disease Type Insights

The degenerative disc segment dominated the market for spinal fusion devices and accounted for the largest revenue share of over 42.0% in 2023. Growing reasons for lower back pain and neck pain in adults and an upsurge in elderly population are the major aspects driving the segment. In addition, rise in sports and daily activities is expected to augment segment growth.

The complex deformity segment is expected to grow fast in the market for spinal fusion devices over the forecast period. The demographics of the elderly population in the U.S. are experiencing a fundamental shift as medical care improvements and life expectancy increases. Moreover, the baby boomers represent the fastest rising demographic in the U.S. and the number of individuals 65 years and elder are projected to reach 89 million by 2050, more than double its existing size which is further boosting the revenue.

Surgery Insights

The minimally invasive surgery segment dominated the market for spinal fusion devices and accounted for the largest revenue share of 64.0% in 2023 as it’s the first preference for spinal fusion surgeries. According to a survey in 2022 in the U.S., the 3 most significant parameters for patients when selecting between MIS and open surgery were: surgeon's recommendation, complication risk, and long-term outcomes. When compared with MIS surgery, most patients experienced open surgery to be more painful, increased complication risk, increased recovery time, and need heavier sedation. Besides, if required to have spine surgery in the future, most of both patient groups would choose a minimally invasive approach. The aforementioned factors are expected to propel the revenue over the forecast period.

End-user Insights

The hospitals dominated the market for spinal fusion devices and accounted for the largest revenue share of over 60.0% in 2023. The growing number of spinal surgeries performed at hospitals is one of the factors driving the segment. Growing government initiatives to improve the healthcare infrastructure and expanding the middle-class population in developing nations such as India are resulting in increasing demand for quality healthcare services delivered by hospitals, thereby aiding segment growth.

Spinal Fusion Device Market Share, By End-use, 2023 (%)

The specialty clinics segment is expected to grow fast in the market for spinal fusion devices over the forecast period. The popularity of these clinics is increasing over years. With the need for improved access to care, numerous types of specialty clinics have come to market over the last two decades. In addition, the increasing demand for better healthcare services has opened scope for new opportunities in delivering affordable healthcare services. Specialty clinics would mainly help in bridging the gap between the demand and supply of healthcare services and facilities by providing superior care. Hence, the aforementioned factors will support segment growth during the forecast period.

Regional Insights

North America dominated the spinal fusion devices market and accounted for the largest revenue share of over 43.0% in 2023. The rising geriatric population, growing spinal disorder and increasing incidence of sports injuries and fatal accidents are among key factors boosting the demand for spinal fusion devices in North America. In addition, the presence of well-established healthcare infrastructure is expected to propel market growth in the region. Moreover, developments by key players are expected to boost market growth with huge untapped opportunities. In April 2022, Orthofix launched M6-C artificial cervical disc, the first commercial implant to increase its market penetration.

Spinal Fusion Device Market Share, By Region 2023 (%)

In Asia Pacific, the market for spinal fusion devices is expected to grow fast over the forecast period. The growth can be attributed to an increased number of medical tourism and government initiatives. Moreover, the growing target population in this region is further increasing the risk of spinal diseases and joint problems. In India, the market for spinal fusion devices is expected to show lucrative growth over the forecast period. The growth can be attributed to increased medical tourism in India for spinal fusion surgeries. There has been a 15 to 20% increase in the patient footfall in India for spinal fusion surgeries in the last 5 years, thus propelling demand.

Some of the prominent players in the Spinal fusion device include:

  • Johnson & Johnson Services, Inc. (DePuy Synthes)
  • Stryker
  • Zimmer Biomet
  • Orthofix Medical, Inc.
  • B. Braun Melsungen AG
  • Medtronic
  • NuVasive, Inc.
  • Globus Medical
  • ATEC Spine, Inc
  • Captiva Spine, Inc
  • SeaSpine
  • Spinal Elements, Inc.
  • Spine Wave, Inc.
  • Spineology, Inc.
  • Xtant Medical Holdings, Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global spinal fusion device.

Product

  • Thoracolumbar Devices    
    • Anterior Lumbar Plates
    • Pedicle Screw and Rods
    • Others
  • Cervical Fixation Devices  
    • Anterior Cervical Plates
    • Hook Fixation Systems
    • Others
  • Interbody Fusion Devices 

Disease Type

  • Degenerative Disc
  • Complex Deformity
  • Trauma & Fractures
  • Others

Surgery

  • Open spine surgery
  • Minimally Invasive Spine Surgery

End-user

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global spinal fusion device size was reached at USD 6.50 billion in 2023 and it is projected to hit around USD 10.19 billion by 2033.

The global spinal fusion device is growing at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2033.

The North America region has accounted for the largest spinal fusion device share in 2024.

The major players operating in the spinal fusion device market are Johnson & Johnson Services, Inc. (DePuy Synthes); Stryker; Zimmer Biomet; Orthofix Medical, Inc.; B. Braun Melsungen AG; Medtronic; NuVasive, Inc.; Globus Medical; ATEC Spine, Inc; Captiva Spine, Inc; SeaSpine; Spinal Elements, Inc.; Spine Wave, Inc.; Spineology, Inc.; Xtant Medical Holdings, Inc.

Chapter 1 Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Market Definition

1.3. Information Procurement

1.3.1. Purchased Database

1.3.2. Internal Database

1.3.3. Secondary Sources & Third-Party Perspectives

1.3.4. Primary Research

1.4. Information Analysis

1.4.1. Data Analysis Models

1.5. Market Formulation & Data Visualization

1.6. Data Validation & Publishing

Chapter 2 Executive Summary

2.1 Market Outlook

Chapter 3 Spinal Fusion Devices Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.1.1 Parent Market Outlook

3.1.2 Ancillary Market Outlook

3.2 Penetration and Growth Prospect Mapping

3.3. Spinal Fusion Devices Market Dynamics

3.3.1. Market Driver Analysis

3.3.2. Market Restraint Analysis

3.4. Spinal Fusion Devices Industry Analysis - Porter’s

3.4.1. Supplier Power

3.4.2. Buyer Power

3.4.3. Substitution Threat

3.4.4. Threat of New Entrants

3.4.5. Competitive Rivalry

3.5. Spinal Fusion Devices Industry Analysis - PEST

3.5.1. Political & Legal Landscape

3.5.2. Economic Landscape

3.5.3. Social Landscape

3.6 Reimbursement Scenario

3.7 Technology Overview

Chapter 4 Covid-19 Impact Analysis

4.1 COVID-19 Outbreak

4.2 Strategies Adopted by Market Players

Chapter 5 Spinal Fusion Devices Market - Competitive Analysis

5.1 Recent Developments & Impact Analysis, By Key Market Participants

5.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)

5.3 Public Companies

5.3.1 Company market share/position analysis

5.3.2 Competitive dashboard analysis

5.3.3 Synergy Analysis: Major Deals & Strategic Alliances

5.4 Private Companies

5.4.1 List of key emerging companies

Chapter 6 Spinal Fusion Devices Market: Product Estimates & Trend Analysis

6.1 Product Movement Analysis & Market Share, 2024 & 2030

6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033 for the following:

6.3 Thoracolumbar Devices

6.3.1 Thoracolumbar Devices Market, 2021 to 2033

6.3.2 Anterior Lumbar Plates

6.3.2.1 Anterior Lumbar Plates Market, 2021 to 2033

6.3.3 Pedicle Screw and Rods

6.3.3.1 Pedicle Screw and Rods Market, 2021 to 2033

6.3.4 Others

6.3.4.1 Others Market, 2021 to 2033

6.4 Cervical Fixation Devices

6.4.1 Cervical Fixation Devices Market, 2021 to 2033

6.4.2 Anterior Cervical Plates

6.4.2.1 Anterior Cervical Plates Market, 2021 to 2033

6.4.3 Hook Fixation Systems

6.4.3.1 Hook Fixation Systems Market, 2021 to 2033

6.4.4 Others

6.4.4.1 Others Market, 2021 to 2033

6.5 Interbody Fusion Devices

6.5.1 Interbody Fusion Devices Market, 2021 to 2033

Chapter 7 Spinal Fusion Devices Market: Disease Type Estimates & Trend Analysis

7.1 Disease Type Movement Analysis & Market Share, 2024 & 2030

7.2 Market Size & Forecasts and Trend Analysis, 2021 to 2033 for the following:

7.3 Degenerative Disc

7.3.1 Degenerative Disc Market, 2021 to 2033

7.4 Complex Deformity

7.4.1 Complex Deformity Market, 2021 to 2033

7.5 Trauma & Fractures

7.5.1 Trauma & Fractures Market, 2021 to 2033

7.6 Others

7.6.1 Others Market, 2021 to 2033

Chapter 8 Spinal Fusion Devices Market: Surgery Estimates and Trend Analysis

8.1 Surgery Type Analysis & Market Share, 2024 & 2030

8.2 Market Size & Forecasts and Trend Analysis, 2021 to 2033 for the following:

8.3 Open spine surgery

8.3.1 Open spine surgery Market, 2021 to 2033

8.4 Minimally Invasive Spine Surgery

8.4.1 Minimally Invasive Spine Surgery Market, 2021 to 2033

Chapter 9 Spinal Fusion Devices Market: End-User Estimates and Trend Analysis

9.1 End User Type Movement Analysis & Market Share, 2024 & 2030

9.2 Market Size & Forecasts and Trend Analysis, 2021 to 2033 for the following:

9.3 Hospitals

9.3.1 Hospitals Market, 2021 to 2033

9.4 Specialty Clinics

9.4.1 Specialty Clinics Market, 2021 to 2033

9.5 Others

9.5.1 Others Market, 2021 to 2033

Chapter 10 Spinal Fusion Devices Market: Regional Estimates & Trend Analysis

10.1 Regional Market Snapshot

10.2 Regional Movement Analysis & Market Share, 2024 & 2030

10.3 North America

10.3.1 North America Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.3.2 U.S.

10.3.2.1 U.S. Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.3.3 Canada

10.3.3.1 Canada Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.4 Europe

10.4.1 Europe Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.4.2 U.K.

10.4.2.1 U.K. Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.4.3 Germany

10.4.3.1 Germany Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.4.4 France

10.4.4.1 France Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.4.5 Italy

10.4.5.1 Italy Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.4.6 Spain

10.4.6.1 Spain Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.5 Asia Pacific

10.5.1 Asia Pacific Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.5.2 Japan

10.5.2.1 Japan Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.5.3 China

10.5.3.1 China Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.5.4 India

10.5.4.1 India Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.6 Latin America

10.6.1 Latin America Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.6.2 Mexico

10.6.2.1 Mexico Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.6.3 Brazil

10.6.3.1 Brazil Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.6.4 Argentina

10.6.4.1 Argentina Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.7 Middle East and Africa

10.7.1 Middle East and Africa Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.7.2 South Africa

10.7.2.1 South Africa Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

10.7.3 Saudi Arabia

10.7.3.1 Saudi Arabia Spinal Fusion Devices Market estimates and forecasts, 2021 - 2033

Chapter 11 Company Profiles

11.1 Johnson & Johnson Services, Inc. (DePuy Synthes)

11.1.1 Company overview

11.1.2 Financial performance

11.1.3 Product benchmarking

11.1.4 Strategic initiatives

11.2 Stryker

11.2.1 Company overview

11.2.2 Financial performance

11.2.3 Product benchmarking

11.2.4 Strategic initiatives

11.3 Zimmer Biomet

11.3.1 Company overview

11.3.2 Financial Performance

11.3.3 Product benchmarking

11.3.4 Strategic initiatives

11.4 Orthofix Medical, Inc.

11.4.1 Company overview

11.4.2 Financial Performance

11.4.3 Product benchmarking

11.4.4 Strategic initiatives

11.5 B. Braun Melsungen AG

11.5.1 Company overview

11.5.2 Product benchmarking

11.5.3 Strategic initiatives

11.6 Medtronic

11.6.1 Company overview

11.6.2 Financial Performance

11.6.3 Product benchmarking

11.6.4 Strategic initiatives

11.7 NuVasive, Inc.

11.7.1 Company overview

11.7.2 Financial Performance

11.7.3 Product benchmarking

11.7.4 Strategic initiatives

11.8 Globus Medical

11.8.1 Company overview

11.8.2 Financial Performance

11.8.3 Product benchmarking

11.8.4 Strategic initiatives

11.9 ATEC Spine, Inc

11.9.1 Company overview

11.9.2 Financial performance

11.9.3 Product benchmarking

11.9.4 Strategic initiatives

11.10 Captiva Spine, Inc

11.10.1 Company overview

11.10.2 Financial performance

11.10.3 Product benchmarking

11.10.4 Strategic initiatives

11.11 SeaSpine

11.11.1 Company overview

11.11.2 Financial performance

11.11.3 Product benchmarking

11.11.4 Strategic initiatives

11.12 Spinal Elements, Inc.

11.12.1 Company overview

11.12.2 Financial performance

11.12.3 Product benchmarking

11.12.4 Strategic initiatives

11.13 Spine Wave, Inc.

11.13.1 Company overview

11.13.2 Financial performance

11.13.3 Product benchmarking

11.13.4 Strategic initiatives

11.14 Spineology, Inc.

11.14.1 Company overview

11.14.2 Financial performance

11.14.3 Product benchmarking

11.14.4 Strategic initiatives

11.15 Xtant Medical Holdings, Inc.

11.15.1 Company overview

11.15.2 Financial performance

11.15.3 Product benchmarking

 

11.15.4 Strategic initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers